Compare Ascendis Pharma A/S (ASND) vs M&T Bank Corporation (MTB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ascendis Pharma A/S vs M&T Bank Corporation — how do they compare? Ascendis Pharma A/S trades at $253.76 (market cap $16.67B), while M&T Bank Corporation trades at $251.93 (market cap $36.42B). The key difference: M&T Bank Corporation is far larger — about 2.2× Ascendis Pharma A/S's market cap, and M&T Bank Corporation pays a 2.38% dividend while Ascendis Pharma A/S pays none. Which is the better fit depends on your goals.
| ASND | MTB | |
|---|---|---|
Market Cap | $16.67B | $36.42B |
Sector | Health | Financials |
52-Week High | $277.18 | $254.04 |
52-Week Low | $189.74 | $178.63 |
Enterprise Value | $17.04B | — |
Dividend Yield | — | 2.38% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Ascendis Pharma A/S
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →About M&T Bank Corporation
M&T Bank is one of the largest regional banks in the United States, with branches in New York, Pennsylvania, West Virginia, Virginia, Maryland, Delaware, and New Jersey. The bank was founded to serve manufacturing and trading businesses around the Erie Canal and is primarily focused on commercial real estate and commercial-related lending, with some retail operations also present.
Read more on MTB →
